Literature DB >> 28940483

Improved quantitative 90 Y bremsstrahlung SPECT/CT reconstruction with Monte Carlo scatter modeling.

Yuni K Dewaraja1, Se Young Chun2, Ravi N Srinivasa1, Ravi K Kaza1, Kyle C Cuneo3, Bill S Majdalany1, Paula M Novelli4, Michael Ljungberg5, Jeffrey A Fessler6.   

Abstract

PURPOSE: In 90 Y microsphere radioembolization (RE), accurate post-therapy imaging-based dosimetry is important for establishing absorbed dose versus outcome relationships for developing future treatment planning strategies. Additionally, accurately assessing microsphere distributions is important because of concerns for unexpected activity deposition outside the liver. Quantitative 90 Y imaging by either SPECT or PET is challenging. In 90 Y SPECT model based methods are necessary for scatter correction because energy window-based methods are not feasible with the continuous bremsstrahlung energy spectrum. The objective of this work was to implement and evaluate a scatter estimation method for accurate 90 Y bremsstrahlung SPECT/CT imaging.
METHODS: Since a fully Monte Carlo (MC) approach to 90 Y SPECT reconstruction is computationally very demanding, in the present study the scatter estimate generated by a MC simulator was combined with an analytical projector in the 3D OS-EM reconstruction model. A single window (105 to 195-keV) was used for both the acquisition and the projector modeling. A liver/lung torso phantom with intrahepatic lesions and low-uptake extrahepatic objects was imaged to evaluate SPECT/CT reconstruction without and with scatter correction. Clinical application was demonstrated by applying the reconstruction approach to five patients treated with RE to determine lesion and normal liver activity concentrations using a (liver) relative calibration.
RESULTS: There was convergence of the scatter estimate after just two updates, greatly reducing computational requirements. In the phantom study, compared with reconstruction without scatter correction, with MC scatter modeling there was substantial improvement in activity recovery in intrahepatic lesions (from > 55% to > 86%), normal liver (from 113% to 104%), and lungs (from 227% to 104%) with only a small degradation in noise (13% vs. 17%). Similarly, with scatter modeling contrast improved substantially both visually and in terms of a detectability index, which was especially relevant for the low uptake extrahepatic objects. The trends observed for the phantom were also seen in the patient studies where lesion activity concentrations and lesion-to-liver concentration ratios were lower for SPECT without scatter correction compared with reconstruction with just two MC scatter updates: in eleven lesions the mean uptake was 4.9 vs. 7.1 MBq/mL (P = 0.0547), the mean normal liver uptake was 1.6 vs. 1.5 MBq/mL (P = 0.056) and the mean lesion-to-liver uptake ratio was 2.7 vs. 4.3 (P = 0.0402) for reconstruction without and with scatter correction respectively.
CONCLUSIONS: Quantitative accuracy of 90 Y bremsstrahlung imaging can be substantially improved with MC scatter modeling without significant degradation in image noise or intensive computational requirements.
© 2017 American Association of Physicists in Medicine.

Entities:  

Keywords:  90Y; SPECT/CT; bremsstrahlung; radioembolization; reconstruction

Mesh:

Substances:

Year:  2017        PMID: 28940483      PMCID: PMC5734647          DOI: 10.1002/mp.12597

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  30 in total

1.  Unmatched projector/backprojector pairs in an iterative reconstruction algorithm.

Authors:  G L Zeng; G T Gullberg
Journal:  IEEE Trans Med Imaging       Date:  2000-05       Impact factor: 10.048

Review 2.  Radioembolization dosimetry: the road ahead.

Authors:  Maarten L J Smits; Mattijs Elschot; Daniel Y Sze; Yung H Kao; Johannes F W Nijsen; Andre H Iagaru; Hugo W A M de Jong; Maurice A A J van den Bosch; Marnix G E H Lam
Journal:  Cardiovasc Intervent Radiol       Date:  2014-12-24       Impact factor: 2.740

3.  Recovery of total I-131 activity within focal volumes using SPECT and 3D OSEM.

Authors:  Kenneth F Koral; Anastasia Yendiki; Yuni K Dewaraja
Journal:  Phys Med Biol       Date:  2007-01-16       Impact factor: 3.609

4.  Development and evaluation of an improved quantitative (90)Y bremsstrahlung SPECT method.

Authors:  Xing Rong; Yong Du; Michael Ljungberg; Erwann Rault; Stefaan Vandenberghe; Eric C Frey
Journal:  Med Phys       Date:  2012-05       Impact factor: 4.071

Review 5.  Radioembolization of hepatic tumors.

Authors:  Andrew Kennedy
Journal:  J Gastrointest Oncol       Date:  2014-06

Review 6.  Radioimmunotherapy of lymphoma: Bexxar and Zevalin.

Authors:  Stanley J Goldsmith
Journal:  Semin Nucl Med       Date:  2010-03       Impact factor: 4.446

7.  Quantitative Monte Carlo-based 90Y SPECT reconstruction.

Authors:  Mattijs Elschot; Marnix G E H Lam; Maurice A A J van den Bosch; Max A Viergever; Hugo W A M de Jong
Journal:  J Nucl Med       Date:  2013-08-01       Impact factor: 10.057

8.  A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.

Authors:  Nima Kokabi; James R Galt; Minzhi Xing; Juan C Camacho; Bruce J Barron; David M Schuster; Hyun S Kim
Journal:  J Vasc Interv Radiol       Date:  2014-02       Impact factor: 3.464

9.  Correction for collimator-detector response in SPECT using point spread function template.

Authors:  Se Young Chun; Jeffrey A Fessler; Yuni K Dewaraja
Journal:  IEEE Trans Med Imaging       Date:  2012-10-18       Impact factor: 10.048

Review 10.  Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective.

Authors:  Marta Cremonesi; Carlo Chiesa; Lidia Strigari; Mahila Ferrari; Francesca Botta; Francesco Guerriero; Concetta De Cicco; Guido Bonomo; Franco Orsi; Lisa Bodei; Amalia Di Dia; Chiara Maria Grana; Roberto Orecchia
Journal:  Front Oncol       Date:  2014-08-19       Impact factor: 6.244

View more
  11 in total

1.  Assessing Spatial Concordance Between Theranostic Pairs Using Phantom and Patient-Specific Acceptance Criteria: Application to 99mTc-MAA SPECT/90Y-Microsphere PET.

Authors:  Justin K Mikell; Bill S Majdalany; Dawn Owen; Kelly C Paradis; Yuni K Dewaraja
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-04-22       Impact factor: 7.038

2.  Algorithms and Analyses for Joint Spectral Image Reconstruction in Y-90 Bremsstrahlung SPECT.

Authors:  Se Young Chun; Minh Phuong Nguyen; Thanh Quoc Phan; Hanvit Kim; Jeffrey A Fessler; Yuni K Dewaraja
Journal:  IEEE Trans Med Imaging       Date:  2019-10-23       Impact factor: 10.048

3.  Feasibility of imaging 90 Y microspheres at diagnostic activity levels for hepatic radioembolization treatment planning.

Authors:  Britt Kunnen; Martijn M A Dietze; Arthur J A T Braat; Marnix G E H Lam; Max A Viergever; Hugo W A M de Jong
Journal:  Med Phys       Date:  2020-01-20       Impact factor: 4.071

4.  Prediction of Tumor Control in 90Y Radioembolization by Logit Models with PET/CT-Based Dose Metrics.

Authors:  Yuni K Dewaraja; Theresa Devasia; Ravi K Kaza; Justin K Mikell; Dawn Owen; Peter L Roberson; Matthew J Schipper
Journal:  J Nucl Med       Date:  2019-05-30       Impact factor: 10.057

5.  A deep neural network for fast and accurate scatter estimation in quantitative SPECT/CT under challenging scatter conditions.

Authors:  Haowei Xiang; Hongki Lim; Jeffrey A Fessler; Yuni K Dewaraja
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-05-15       Impact factor: 9.236

6.  Y-90 SPECT ML image reconstruction with a new model for tissue-dependent bremsstrahlung production using CT information: a proof-of-concept study.

Authors:  Hongki Lim; Jeffrey A Fessler; Scott J Wilderman; Allen F Brooks; Yuni K Dewaraja
Journal:  Phys Med Biol       Date:  2018-05-22       Impact factor: 3.609

7.  Biodistribution, pharmacokinetics, and organ-level dosimetry for 188Re-AHDD-Lipiodol radioembolization based on quantitative post-treatment SPECT/CT scans.

Authors:  Pedro L Esquinas; Ajit Shinto; Koramadai K Kamaleshwaran; Jephy Joseph; Anna Celler
Journal:  EJNMMI Phys       Date:  2018-12-07

Review 8.  Current Status of Radiopharmaceutical Therapy.

Authors:  Sara St James; Bryan Bednarz; Stanley Benedict; Jeffrey C Buchsbaum; Yuni Dewaraja; Eric Frey; Robert Hobbs; Joseph Grudzinski; Emilie Roncali; George Sgouros; Jacek Capala; Ying Xiao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-08-14       Impact factor: 7.038

9.  Relationship of radiation dose to efficacy of radioembolization of liver metastasis from breast cancer.

Authors:  Fourat Ridouani; Mohamed M Soliman; Ryan W England; Meier Hsu; Chaya S Moskowitz; Raphael Doustaly; Constantinos T Sofocleous; F Edward Boas; Hooman Yarmohammadi; Amy R Deipolyi
Journal:  Eur J Radiol       Date:  2021-01-12       Impact factor: 3.528

10.  The value of 99mTc-MAA SPECT/CT for lung shunt estimation in 90Y radioembolization: a phantom and patient study.

Authors:  Jonathan D Allred; Jeremy Niedbala; Justin K Mikell; Dawn Owen; Kirk A Frey; Yuni K Dewaraja
Journal:  EJNMMI Res       Date:  2018-06-15       Impact factor: 3.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.